ID

11850

Descrizione

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology; ODM derived from: https://clinicaltrials.gov/show/NCT02140736

collegamento

https://clinicaltrials.gov/show/NCT02140736

Keywords

versioni (1)
  1. 10/08/15 10/08/15 - Julian Varghese
Caricato su

10 agosto 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Chemotherapy-induced Symptomatic Anemia NCT02140736

Inglese

Eligibility Chemotherapy-induced Symptomatic Anemia NCT02140736

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

patients of more than 18 years of age
Descrizione

patients of more than 18 years of age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
patients presenting with anemia following chemotherapy
Descrizione

patients presenting with anemia following chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3665472
UMLS CUI [2]
C0002871
patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy
Descrizione

patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0280100
UMLS CUI [2]
C3665472
UMLS CUI [3]
C0376545
- the patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)
Descrizione

- the patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)

Tipo di dati

boolean

patients eligible for epoetin alfa biosimilar treatment
Descrizione

patients eligible for epoetin alfa biosimilar treatment

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013893
UMLS CUI [1,2]
C0357126
Exclusion Criteria
Descrizione

Exclusion Criteria

patients are not receiving chemotherapy
Descrizione

patients are not receiving chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3665472
patients already included in an epoetin zeta trial
Descrizione

patients already included in an epoetin zeta trial

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2242969
UMLS CUI [1,2]
C1997870
patients presenting with a contraindication to epoetin zeta
Descrizione

patients presenting with a contraindication to epoetin zeta

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0522473
UMLS CUI [1,2]
C1997870
patients presenting with hypersensitivity to the active principle or any of the excipients
Descrizione

patients presenting with hypersensitivity to the active principle or any of the excipients

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0014822
patient with erythroblastopenia or acquired pure red cell aplasia (aprca)
Descrizione

patient with erythroblastopenia or acquired pure red cell aplasia (aprca)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0877221
UMLS CUI [2]
C0340961
patient with uncontrollable arterial hypertension
Descrizione

patient with uncontrollable arterial hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1868885
patients who cannot receive adequate prophylaxis by antithrombotic agents
Descrizione

patients who cannot receive adequate prophylaxis by antithrombotic agents

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0522473
UMLS CUI [1,2]
C1704311
Ritorna all'inizio della pagina

Similar models

Eligibility Chemotherapy-induced Symptomatic Anemia NCT02140736

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
age
Item
patients of more than 18 years of age
boolean
C0001779 (UMLS CUI [1])
Chemotherapy | Anemia | Hematologic Neoplasms
Item
patients presenting with anemia following chemotherapy
boolean
C3665472 (UMLS CUI [1])
C0002871 (UMLS CUI [2])
Solid tumour | Chemotherapy | Hematologic Neoplasms
Item
patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy
boolean
C0280100 (UMLS CUI [1])
C3665472 (UMLS CUI [2])
C0376545 (UMLS CUI [3])
patient inclusion regardless of chemotherapy
Item
- the patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)
boolean
Eligibility Determination; Epoetin Alfa
Item
patients eligible for epoetin alfa biosimilar treatment
boolean
C0013893 (UMLS CUI [1,1])
C0357126 (UMLS CUI [1,2])
Chemotherapy
Item
patients are not receiving chemotherapy
boolean
C3665472 (UMLS CUI [1])
clinical trial participant (history); epoetin zeta
Item
patients already included in an epoetin zeta trial
boolean
C2242969 (UMLS CUI [1,1])
C1997870 (UMLS CUI [1,2])
Contraindication; epoetin zeta
Item
patients presenting with a contraindication to epoetin zeta
boolean
C0522473 (UMLS CUI [1,1])
C1997870 (UMLS CUI [1,2])
Hypersensitivity; Erythropoietin
Item
patients presenting with hypersensitivity to the active principle or any of the excipients
boolean
C0020517 (UMLS CUI [1,1])
C0014822 (UMLS CUI [1,2])
Decreased erythroid precursor production | Acquired red cell aplasia
Item
patient with erythroblastopenia or acquired pure red cell aplasia (aprca)
boolean
C0877221 (UMLS CUI [1])
C0340961 (UMLS CUI [2])
Uncontrolled hypertension
Item
patient with uncontrollable arterial hypertension
boolean
C1868885 (UMLS CUI [1])
Contraindication; Antithrombotic Agents
Item
patients who cannot receive adequate prophylaxis by antithrombotic agents
boolean
C0522473 (UMLS CUI [1,1])
C1704311 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial